Experts decry FDA’s halting of a high-profile Covid-19 study over approvals
Regulators at the Food and Drug Administration told STAT the agency’s decision last week to halt a high-profile, Gates Foundation-backed effort to study the spread of coronavirus in the Seattle area came after the researchers involved failed to secure two kinds of needed approval.
The program, called the Seattle Coronavirus Assessment Network, or SCAN, was initially focused on studying the flu but quickly pivoted to track the coronavirus at the outset of the pandemic, making inroads in tracking the spread of the virus and attracting high-profile support from companies like shipping giant Amazon, whose health care arm picked up and delivered Covid-19 tests to healthy and infected people. But the FDA stopped the effort suddenly last week, the New York Times reported.
Read Original Article: Experts decry FDA’s halting of a high-profile Covid-19 study over approvals »
